Remote Continuous Glucose Monitor Approved

On January 4, Medtronic, Inc., announced the approval of its novel mySentry Remote Glucose Monitor, a first-of-its-kind device that allows parents and other caregivers to monitor a person’s glucose trends and insulin pump functions from another room.


The mySentry is composed of a monitor with a color screen and a mySentry Outpost device, which transmits information from the Minimed Paradigm Real-Time Revel System — an insulin pump with built-in continuous glucose monitoring — to the monitor.

The Outpost can communicate from more than 50 feet away to the mySentry monitor, transmitting information that includes continuous glucose monitoring graphs, insulin pump battery life, amount of insulin remaining, and time until the next glucose sensor calibration. The mySentry sounds the same alarms as the Minimed Paradigm Real-Time Revel System, alerting caregivers to impending low or high blood glucose levels and notifying when preset low or high blood glucose levels have been reached. Volumes on the alarms can be adjusted, and alarms can sound loudly to awaken deep sleepers. The device also features a snooze button to temporarily silence alarms.

The mySentry monitor uses touch-sensitive display technology and can be adjusted to varying levels of brightness. An optional privacy display screen is also available to hide sensitive information while allowing alerts to come through.

“Many of the parents of our patients wake up a couple of times every night to check their child’s blood sugar level and even that may not be enough to prevent episodes of severe hypoglycemia,” notes William Tamborlane, MD, Chief of Pediatric Endocrinology and Deputy Director of the Yale Center for Clinical Investigation. “Advances in continuous glucose monitoring, including remote monitoring like mySentry, have given parents an added level of protection from dangerous nighttime hypoglycemia occurring in their sleeping child, as well as a means to improve their quality of life.”

According to the Medtronic press release, the company is “committed to working with health insurance providers to ensure access to and reimbursement for the product.” The mySentry system, which is available for order immediately, costs about $3,000, but Medtronic is offering it at a special promotional price of $2,400 for a limited time. The company is also offering another $500 off for new customers who purchase an insulin pump, continuous glucose monitor, and mySentry in their initial order. Financial assistance is additionally available from Medtronic for customers who meet certain income requirements. Call (800) 646-4633 for more information.

To learn more about the Medtronic mySentry Monitor, read the article “Medtronic mySentry Lets You Watch Your Kid’s Glucose Through the Night,” or see the mySentry page on the Medtronic Web site (which also includes a video illustrating how the device works). And for more information on the MiniMed Paradigm REAL-Time Revel System, click here.

Learn more about the health and medical experts who who provide you with the cutting-edge resources, tools, news, and more on Diabetes Self-Management.
About Our Experts >>

  • Salley Ayers

    Iam a Type1 and Type2 Diabetic! And I am also on Medicaid! I would like to know if I would or could Quialfy For The MiniMed Paradigm REAL-Time Revel System! Iam also on Medicaid! Please Get Back to Me As Soon As Possible!/ tHANKYOU, tHANKyOU!. Salley Ayers

  • rcmodelr

    It would ONLY be beneficial IF it was MUCH MORE ACCURATE AND allowed user to enter Time-Of-Day activity levels…

    I tried the Medtronics CGM system with my Paradigm Revel 723 Pump… I had already been using Dexcom 7 PLUS system… During comparisons… Dexcom 7 Plus system was CONSISTENTLY indicating readings within 30 mg/dl from actual BG reading levels…

    While AT SAME TIME TIME… Medtronic’s “CGM” system was indicating CGM readings as much as 200 mg/dl ABOVE and readings as low as 80 mg/dl BELOW ACTUAL Glucometer readings… ALL while actual GLUCOMETER readings were registering < 60 mg/dl!!! At time Medtronic’s logic was saying my CURRENT Glucose Reading would have been sonewhere around -80, which would mean I would have been declared DEAD at least THREE HOURS PRIOR TO the reading given!!!

  • Nasiru Abubakar

    I am Type 2 diabetes.Am on medication.I would like to know if I can use this device.Pls reply to me as soon as possible.From Nasiru Abubakar,Nigeria.T hank you

  • Nasiru Abubakar

    Pls,I would also want know the mode of payment because am financialy humble.

  • Diane Fennell

    Thank you both for your questions. You can learn more about payment options for the Medtronic mySentry Monitor by calling Medtronic at (800) 646-4633 and pressing option 4.

    Diane Fennell
    Web Editor


    I understand that medicare and medicaid do not financially support the CGM. Well, I would like to know, what is the difference between someone that has private insurance and someone on medicare. These ideas do not make any since to me. A person hurts, no matter what kind of coverage they have.
    About 4 years ago, I called a diabetic lab in Connecticut and I told them my idea of a CGM that you would weir on you arm like a watch, and it would work like a barometer. When the arm moves to a higher number, your blood sugar has increased. When the arm move to a lower number, your blood sugar has decreased. This system also will be a continuous reading of your blood sugar. You would know were you are at all times.
    I still would like to know more about this CGM.
    Thanks, and May GOD Bless, Bill